McCarter is pleased to participate in Delaware’s DNA | 2026 Life Science Conference, the region’s largest gathering of life sciences executives, investors, researchers, and policymakers, taking place April 30 at the Chase Center on the Riverfront.
As part of the conference’s dedicated IP & Legal session, titled “Scaling Smart: Legal Strategies for Growth Companies,” partners Philip Amoa and Jeff Mann will help lead a practical discussion focused on the legal decisions that can either constrain—or enable—growth for early and mid-stage life sciences companies. The panel will also address how companies can make informed choices around IP protection, ownership structure, and investor expectations—critical issues for management teams navigating rapid innovation and evolving market conditions.
